Literature DB >> 10697568

Taxotere activates transcription factor AP-1 in association with apoptotic cell death in gastric cancer cell lines.

R Kim1, Y Ohi, H Inoue, T Toge.   

Abstract

We investigated whether a novel mitotic inhibitor, taxotere can activate the transcription factor AP-1 in association with apoptotic cell death in 8 gastric cancer cell lines. Apoptotic cell death was analyzed by DNA ladder formation assay, and AP-1 binding activity was assessed by gel mobility-shift assay. The activation of AP-1 binding was induced in accordance with the sensitivity to taxotere in gastric cancer cell lines. The relationship between the increase of AP-1 binding and the formation of internucleosomal DNA ladders induced by taxotere was significant (p < 0.05). Furthermore, the activation of AP-1 binding was induced following the treatment of taxotere in a dose and -time dependent manner. Although the sensitivity to taxotere was correlated with the formation of internucleosomal DNA ladders in apoptotic cell death, its sensitivity was not influenced by their p53 genomic states in gastric cancer cell lines. Rather, the activation of AP-1 binding was correlated with the induction of a growth arrest and DNA damage inducible gene, gadd153 (p < 0.05). These results indicate that the activation of AP-1 binding by taxotere seems to be an important factor in determining its sensitivity in association with internucleosomal DNA ladders, and suggest that the induction of gadd153 gene could be a downstream target of AP-1-regulated genes involved in signal transduction pathways leading to apoptosis in gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10697568

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.

Authors:  Hugo Ford; Ioannis Gounaris
Journal:  Therap Adv Gastroenterol       Date:  2015-07       Impact factor: 4.409

Review 2.  Docetaxel: in gastric cancer.

Authors:  Emma D Deeks; Lesley J Scott
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells.

Authors:  V Wacheck; E Selzer; P Günsberg; T Lucas; H Meyer; C Thallinger; B P Monia; B Jansen
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.